ETFs
R
RGLS
Regulus Therapeu
This stock has been delisted.
News
Press Releases
Financial Reports
Profile
TipRanks·06/25/2025 13:29
Regulus Acquired by Novartis, Delisted from Nasdaq
Reuters·06/25/2025 13:15
BRIEF-Novartis Completes Acquisition Of Regulus Therapeutics
Reuters·06/25/2025 13:13
NOVARTIS AG - COMPLETES ACQUISITION OF REGULUS THERAPEUTICS
TipRanks·06/25/2025 10:10
Novartis announces expiration of Regulus Therapeutics tender offer
TipRanks·06/23/2025 17:18
Novartis announces expiration of HSR waiting period of Regulus offer
Seeking Alpha·06/06/2025 19:00
Catalyst Watch: Apple's WWDC event, Chime IPO, BlackRock's Investor Day and fresh inflation reads
Seeking Alpha·06/04/2025 17:48
Regulus Therapeutics: An Undervalued Buy, With A $0.90 CVR And A $7 Payout
Seeking Alpha·05/30/2025 19:00
Catalyst Watch: Crypto buzz with the Circle IPO, Snowflake event and the May Jobs Report
Dow Jones·05/27/2025 12:04
*Correct: Novartis Will Offer $7.00 in Cash Per Share
Dow Jones·05/27/2025 12:01
*Novartis: Offer Will Expire on June 24
Dow Jones·05/27/2025 12:00
*Novartis Will Offer $0.001 Per Share
Dow Jones·05/27/2025 11:59
*Novartis: Offer Is to Acquire All Outstanding Shares of Regulus Therapeutics's Common Stock
Dow Jones·05/27/2025 11:59
*Novartis: Redwood Merger Sub Inc. Is an Indirect Wholly Owned Subsidiary of Novartis
Same Industry
Name/Symbol
Change%
Price